Trials / Sponsors / AVIR Green Hills Biotechnology AG
AVIR Green Hills Biotechnology AG
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults Influenza, Human | Phase 1 / Phase 2 | 2011-01-01 |
| Completed | Dose Finding Study of Single Dose GHB11L1 in Healthy Adults Influenza, Human | Phase 2 | 2009-12-01 |
| Completed | Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults Influenza, Avian | Phase 1 | 2008-12-19 |
| Completed | Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults Influenza | Phase 1 | 2008-08-01 |
| Completed | Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Seasonal Human Influenza | Phase 1 | 2007-03-01 |